8-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 28, 2005

CELANESE CORPORATION
(Exact Name of Registrant as specified in its charter)

DELAWARE
(State or other jurisdiction
of incorporation) 001-32410
(Commission File
Number) 98-0420726
(IRS Employer
Identification No.)

1601 West LBJ Freeway, Dallas, Texas 75234-6034
(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (972) 901-4500

Not Applicable
(Former name or former address, if changed since last report):

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01     Regulation FD Disclosure

     On February 28, 2005, David N. Weidman, President and Chief Executive Officer of Celanese Corporation (the “Company”), and Corliss Nelson, Executive Vice President and Chief Financial Officer of the Company, made a presentation to investors and analysts via webcast and teleconference hosted by the Company. A copy of the slide presentation posted during the webcast and teleconference is attached to this Current Report on Form 8-K (“Current Report”) as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 7.01 disclosure. Additionally, the Company has posted the slide presentation on its website at www.celanese.com under the Investor/Investor Webcast section.

     The information in this Current Report, including the exhibit attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibit, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.

Item 9.01     Financial Statements and Exhibits.

     (c) Exhibits

Exhibit Number	Description
99.1	Slide Presentation dated February 28, 2005

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CELANESE CORPORATION

By: /s/ Corliss J. Nelson          

Name: Corliss J. Nelson

Title: Executive Vice President and
Chief Financial Officer

Date: March 1, 2005

Exhibit Index

Exhibit Number	Description
99.1	Slide Presentation dated February 28, 2005

EX-99

Exhibit 99

Transformation and
Results

Celanese 4Q2004 Earnings
Conference Call/Webcast
Mon., Feb. 28, 2005 10 a.m CT

David Weidman, CEO
C.J. Nelson, CFO

Forward-Looking Statements

This presentation may contain “forward-looking statements,” which include information concerning the Company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this presentation, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.

There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this presentation. Numerous factors, many of which are beyond the Company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. For a discussion of some of the factors, we recommend that you review the Company’s Registration Statement on Form S-1 at the SEC’s website at www.sec.gov. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Reconciliation of Non-GAAP Measures
to U.S. GAAP

This presentation reflects our performance measures, net debt, and Segment Earnings as non-U.S. GAAP measures. The most directly comparable financial measure presented in accordance with U.S. GAAP in our financial statements for net debt is total debt and for Segment Earnings is earnings (loss) from continuing operations before tax and minority interests. This presentation also reflects our debt covenant measure Adjusted EBITDA. The most directly comparable financial measure presented in accordance with U.S. GAAP in our financial statements for this is net earnings (loss). This presentation also reflects the 2004 net sales, operating profit, net income and depreciation and amortization as a summation of these measures derived from (i) the financial statements for the predecessor for the three months ended March 31, 2004, and (ii) the financial statements for the successor for the nine months ended December 31, 2004, for each period prepared on a basis consistent with U.S. GAAP. The combined presentation is not in accordance with GAAP. For a reconciliation of these non-U.S. GAAP measures to U.S. GAAP figures see the accompanying schedules to this presentation. Reconciliations of any forward-looking non-U.S. GAAP measure to U.S. GAAP measures are not available.

Use of Non-GAAP Financial Information

Adjusted EBITDA, a performance measure used by management, is defined as earnings (loss) from continuing operations, plus interest expense net of interest income, income taxes and depreciation and amortization, and further adjusted for certain cash and non-cash charges. Our management believes Adjusted EBITDA is useful to investors because it is used in our debt instruments to determine compliance with financial covenants and our ability to engage in certain activities such as incurring additional debt and making certain payments. Segment Earnings, another performance measure used by management, is defined as earnings (loss) from continuing operations before tax and minority interests excluding depreciation and amortization, special charges, stock appreciation rights and inventory step up.

Adjusted EBITDA and Segment Earnings are the primary measures our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Adjusted EBITDA and Segment Earnings are not recognized terms under U.S. GAAP and do not purport to be alternatives to net earnings as measures of operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical calculations, this presentation of Adjusted EBITDA and Segment Earnings may not be comparable to other similarly titled measures of other companies. Additionally, Adjusted EBITDA and Segment Earnings are not intended to be measures of free cash flow for management’s discretionary use, as they do not consider certain cash requirements such as interest payments, tax payments and debt service requirements. We believe that the presentation of all of the non-GAAP information provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when GAAP information is viewed in conjunction with non-GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. This non-GAAP information is not intended to be considered in isolation or as a substitute for GAAP financial information.

Q4 and ’04 Results

(in $millions)	Q404		Combined FY04
Sales	$1,332 up 15%		$5,069 up 10%
Gross Profit	$303 up 98%		$975 up 35%
Net Earnings (loss)	$(57	)	$(175	)
Dividends from Affiliates	$11		$77
Adjusted EBITDA	$187 up 3%		$801 up 19%

	Strong demand across all lines, regions
	Results occurred during time of transformation

Underlying results reflect strength of strategy

C. J. Nelson

Executive Vice President and Chief Financial Officer

Financial Overview

	Fourth Quarter		Full Year
(in $millions)	Successor	Predecessor	Combined	Predecessor
	2004	2003	2004	2003
Sales	1,332	1,155	5,069	4,603
Gross Profit	303	153	975	720
SG&A	(220)	(126)	(635)	(510)
Special Charges	(33)	(14)	(119)	(5)
Operating Profit (Loss)	28	(10)	130	118
Interest Expense	(72)	(13)	(306)	(49)
Tax	(12)	8	(87)	(53)
Net Earnings (Loss)	(57)	18	(175)	148
Affiliate Dividends	11	29	77	76
Adjusted EBITDA	187	182	801	675

Net Earnings to Adjusted EBITDA walk - 2004

Significant Contribution from Joint Ventures

Joint Venture Investments Drive Strategic Growth and Financial Performance

Note:	(1)	2004 Proportional D&A from affiliates shown is an estimate
	(2)	D&A as presented in the chart above represents the amount recorded by the investees based on local generally accepted accounting principles, computed in proportion to our ownership percentage. These amounts are not included in the D&A reported by Celanese.

Pro Forma Capitalization ⁽¹⁾

			Pro-Forma as of 12/31/04
		December 31, 2004	Post- IPO	With Acquisitions
Cash		$838	$838	$838
	Existing Term Loan B(2)	$624	$0	$0
	New Term Loan B(3)	$0	$1,569	$1,769
	New Delayed Draw Term Loan C	$0	$0	$242
	Floating Rate Term Loan	$350	$0	$0
Total Senior Debt		$974	$1,569	$2,011
	Senior Sub Notes ($)	$1,231	$800	$800
	Senior Sub Notes (€)(4)	$272	$177	$177
	Acetex Notes	$0	$0	$265
	Assumed Debt	$383	$383	$383
	Total Cash Pay Debt	$2,860	$2,929	$3,636
	Discount Notes Series A	$103	$66	$66
	Discount Notes Series B	$424	$276	$276
Total Debt		$3,387	$3,271	$3,978
	Convertible Preferred		$240	$240
	Market Capitalization		$2,741(5)	$2,741(5)
Total Capitalization			$6,252	$6,959

1 Table shows debt balances and pro forma adjustments as of 12/31/04	4	Converted at €1 =$1.3621
2 Includes €125 million of Euro denominated debt (converted at €1 = $1.3621)	5	Based on closing price of $17.27 on 2/25/05
3 Includes €275 million of Euro denominated debt (converted at €1 = $1.3621)

Pension and OPEB Plan Obligations

	Aggressive contributing increased funded status dramatically
	•	Plan contributions of $500 million increased ABO funded status from 77% at FYE ‘03 to 90% at FYE ’04
	Total benefit obligations decreased
	•	Total benefit obligations decreased from $1.165 billion to $1.006 billion as plan contributions offset increases from purchase accounting
	2005 pension contribution expense is half of 2004 levels
	•	As a result of purchase accounting and plan contributions, 2005 pension expense is expected to be $26 million and 2005 OPEB expense is also expected to be $26 million. On a historical basis, 2004 cost was over $110 million
	Under current pension legislation, we do not anticipate making pension plan contributions for the foreseeable future

2004 Capital Expenditures

Business Segment/2005 Outlook

David Weidman
Chief Executive Officer

2004 Business Highlights

	Vinamul acquisition* extends Acetyls chain
	Announced Acetex acquisition provides for reliable supply to global market
	Acetate restructuring to enhance profitability of a leading Celanese business
	Nanjing, China plant becoming reality
	SG&A actions in all major businesses and administrative centers
	Procurement initiatives on track

* Announced ’04, completed ‘05

Chemicals Products Historical Perspective:

	Margin expansion in Q4 and full year
	Strong demand, favorable pricing in all regions during year, and improved productivity
	Fourth quarter results particularly strong

(in $millions)
	Q404	FY2004 Combined
Sales	$925 up 21%	$3,391 up 11%
Segment Earnings(1)	$142 up 78%	$476 up 38%

(1) – Earnings from continuing operations before tax and minority interests excluding Depreciation and amortization, Special Charges, Stock Appreciation Rights, Inventory Step up

Chemical Products Outlook

1st Quarter
	Sustained demand, favorable pricing
	Modest raw material increases
	Margin momentum continues
Full Year
	Sustained demand pricing
	Southern Methanol decreases Gulf Coast gas exposure
	Ethylene price relief from contracts
	Second half supply/demand balance to loosen on expansions
	Positive pricing momentum in downstream Celanese products

Ticona Historical Perspective

	Solid ’04 volume growth of 13%, all lines contributing
	Raw material increases offset by volume growth during year
	Q4 volume growth rate declines but is still strong at 6%
	Q4 profit erosion due to raw materials, price, and effects of maintenance turnaround
	$32 million impairment charge for planned COC sale

(in $millions)
	Q404	FY2004 Combined
Sales	$203 up 8%	$863 up 13%
Segment Earnings(1)	$18 down 28%	$192 up 28%

(1) – Earnings from continuing operations before tax and minority interests excluding Depreciation and amortization, Special Charges, Stock Appreciation Rights, Inventory Step up

Ticona Outlook

1st Quarter
	Continuation of slowed demand and raw material pressures
Full Year
	Earnings growth momentum to pick up in second half and beyond after temporary correction in key markets

Acetate/Performance Products Summaries

Acetate
	Stable financial results continue
	Focus is on completion of restructuring plan and significant benefits
Performance Products
	Strong earnings in full year on Sunett volume growth
	Profitability will decline after patent expiration in March ’05, but will remain high margin business

Combined Business Outlook

1st Quarter
	25-30% increase in adjusted EBITDA vs. Q1 ’04
	Reflective of strong business growth and affiliate dividends
Full Year
	12-17% growth in adjusted EBITDA vs. ‘04
	Reflective of strong business environment, methanol agreement and acquisitions

Appendix

Appendix – Full Year 2005 Key Modeling Assumptions

		Equity – CE Shares
•	Common stock = 158.7 million outstanding
•	Fully diluted common stock = 170.7 million
•	Preferred stock dividends = approx. $10 million on 9.6 million outstanding shares
Equity – CAG Minority Interest
•	Approximately 8 million shares outstanding as of February 16
•	Current tender offer price = €41.92/share
•	Net guaranteed payment = approximately €24 million
Capital Expenditures
•	Capital expenditures = $210 - $230

			Income Statement ($ millions)
•	Depreciation = $230-$250
•	Special charges = $30-$50
•	Interest expense = $250-$260
		•	Excluding deferred finance/debt premium of approx. $115
		•	Avg cost of borrowed capital = 7%
•	Effective tax rate of 34% to 37%
•	Monitoring fee
		•	Annual fee $10
		•	Cancellation $35
		•	Terminated Jan ’05

Reconciliation of Segment Earnings

			Q4 2004 Successor							Q4 2003 Predecessor
		Technical							Technical
	Chemical	Polymers		Acetate	Performance	Other		Chemical	Polymers	Acetate	Performance	Other
	Products	Ticona		Products	Products	Activities	Total	Products	Ticona	Products	Products	Activities	Total
Earnings(loss) from Continuing Operations
before Tax and Minority Interests	131	(29)		18	3	(162)	(39)	35	(9)	2	11	(42)	(3)
Depreciation and Amortization	12	14		3	5	0	34	41	14	23	1	2	81
Special Charges	(1)	33		0	0	1	33	0	16	0	0	(2)	14
Stock Appreciation Rights	0	0		0	0	0	0	4	4	1	0	9	18
Purchase Accounting for Inventories	0	0		0	0	0	0	0	0	0	0	0	0
Segment Earnings	142	18		21	8	(161)	28	80	25	26	12	(33)	110
		FY 2004 Combined							FY 2003 Predecessor
		Technical							Technical
	Chemical	Polymers		Acetate	Performance	Other		Chemical	Polymers	Acetate	Performance	Other
	Products	Ticona		Products	Products	Activities	Total	Products	Ticona	Products	Products	Activities	Total
Earnings(loss) from Continuing Operations
before Tax and Minority Interests	329	71		2	26	(530)	(102)	175	167	17	(44)	(119)	196
Depreciation and Amortization	128	64		46	12	6	256	157	57	66	7	7	294
Special Charges	4	38		50	0	27	119	(1)	(87)	0	95	(2)	5
Stock Appreciation Rights	0	1		0	0	0	1	14	13	4	1	27	59
Purchase Accounting for Inventories	15	18		4	12	0	49	0	0	0	0	0	0
Segment Earnings	476	192		102	50	(497)	323	345	150	87	59	(87)	554